Novo Nordisk Second Quarter Sales Increase by 18%

Novo Nordisk, the maker of Wegovy, reported an 18% increase in sales in the second quarter. This growth comes after a major profit warning and the announcement of a new CEO, which led to a significant decrease in the company's stock value.

Latest News

08-06
Novo Nordisk A/S reports results for the quarter ended June 30 - Earnings Summary
Novo Nordisk A/S reports results for the quarter ended June 30 - Earnings Summary
08-06
Novo Nordisk Q2 Earnings, Revenue Rise; Trims 2025 Revenue Guidance
Novo Nordisk Q2 Earnings, Revenue Rise; Trims 2025 Revenue Guidance
08-06
Wegovy Maker Novo Nordisk Sales Rise 18% In Second Quarter
Wegovy Maker Novo Nordisk Sales Rise 18% In Second Quarter
08-06
诺和诺德:减肥药Wegovy第二季度销售额达195.3亿丹麦克朗预估192 亿丹麦克朗。
诺和诺德:减肥药Wegovy第二季度销售额达195.3亿丹麦克朗预估192 亿丹麦克朗。

User Discussion

A lot of obstacles though making $